Rapport Therapeutics, Inc.
RAPP • NASDAQ
Rapport Therapeutics, Inc. is a publicly traded company trading on NASDAQ, led by CEO Abraham N. Ceesay, with a market cap of $1.6B.
Market Cap$1.6B
CEOAbraham N. Ceesay
CountryUnited States of America
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Rapport Therapeutics, Inc. FAQ
Common questions about Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $12.0M.